Immunotherapies in Relapsed/Refractory Multiple Myeloma: 2021 Round-Up and a Look Into the Future

Listen to the updates of immunotherapy in multiple myeloma and the implication they may have on clinical practice. Credit available for this activity expires: 2/3/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/967762?src=mkm_podcast_addon_967762